XRN2 Antikörper (AA 1-50)
-
- Target Alle XRN2 Antikörper anzeigen
- XRN2 (5'-3' Exoribonuclease 2 (XRN2))
-
Bindungsspezifität
- AA 1-50
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser XRN2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit anti-XRN2 Antibody, Affinity Purified
- Homologie
- Chicken,Orangutan
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 1 and 50
- Isotyp
- IgG
- Top Product
- Discover our top product XRN2 Primärantikörper
-
anti-5'-3' Exoribonuclease 2 (XRN2) (AA 398-547) antibody
XRN2 Reaktivität: Human WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 9F7G11 unconjugated
anti-5'-3' Exoribonuclease 2 (XRN2) antibodyXRN2 Reaktivität: Human, Maus, Affe WB, ELISA, IHC, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-5'-3' Exoribonuclease 2 (XRN2) (AA 81-130) antibodyXRN2 Reaktivität: Human, Maus WB, ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-5'-3' Exoribonuclease 2 (XRN2) (N-Term) antibodyXRN2 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-5'-3' Exoribonuclease 2 (XRN2) (N-Term) antibodyXRN2 Reaktivität: Human, Maus, Affe WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-5'-3' Exoribonuclease 2 (XRN2) (AA 48-76) antibodyXRN2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
IP: Not recommended. Use rabbit anti-XRN2 antibody A301-103A.
WB: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 200 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- XRN2 (5'-3' Exoribonuclease 2 (XRN2))
- Andere Bezeichnung
- XRN2 (XRN2 Produkte)
- Synonyme
- zgc:55717 antikoerper, wu:fb38g12 antikoerper, wu:fj53d06 antikoerper, AO090012000503 antikoerper, DKFZp459J063 antikoerper, AtXRN2 antikoerper, EXORIBONUCLEASE 2 antikoerper, K16E1.2 antikoerper, K16E1_2 antikoerper, exoribonuclease 2 antikoerper, 5'-3' exoribonuclease 2 antikoerper, 5'-3' exoribonuclease 2, putative antikoerper, 5'-3' exoribonuclease 2 S homeolog antikoerper, exoribonuclease 2 antikoerper, xrn2 antikoerper, XRN2 antikoerper, TA11675 antikoerper, LELG_04162 antikoerper, AOR_1_874194 antikoerper, PTRG_01514 antikoerper, PTRG_10866 antikoerper, Tsp_08094 antikoerper, xrn2.S antikoerper, Xrn2 antikoerper
- Hintergrund
- Background: XRN2 is a 5'-to-3' exoribonuclease involved in 3'-end mRNA processing. XRN2 is important for transcription termination and is responsible for degrading the downstream 3'-end-cleaved RNA. Recent studies show that XRN2 is recruited to 3'-end processing machinery by p54nrb/PSF.
- Gen-ID
- 22803
- NCBI Accession
- NP_036387
- UniProt
- Q9H0D6
-
